Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lim

Showing results (1461-1470 of 1,673) with videos related to

Pageof 168
Sort By:
Annals of Neurology|December 22, 2022
APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer PathologyAxel D Meneses, Shunsuke Koga, Zonghua Li, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic CancersErica S Tsang, Cameron J Grisdale, Erin Pleasance, et al.
Science (New York, N.Y.)|September 1, 2022
Cyclic ADP ribose isomers: Production, chemical structures, and immune signalingMohammad K Manik, Yun Shi, Sulin Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2020
Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencingMy Linh Thibodeau, Kieran O'Neill, Katherine Dixon, et al.
Cancer Discovery|September 22, 2020
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in <i>PIK3CA</i>-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Joline S J Lim, Iain R Macpherson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast CancerJoline S J Lim, Andrea L A Wong, Samuel G W Ow, et al.
Nature Communications|November 12, 2025
A non-canonical lymphoblast in refractory childhood T-cell leukaemiaBram S J Lim, Holly J Whitfield, Mi K Trinh, et al.
Acta Neurochirurgica|February 24, 2001
A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular DiseaseD H Han, O K Kwon, B J Byun, et al.
Annals of Surgical Oncology|September 7, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Pageof 168

Showing results (1461-1470 of 1,673) with videos related to

Sort By:
Pageof 168
Annals of Neurology|December 22, 2022
APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer PathologyAxel D Meneses, Shunsuke Koga, Zonghua Li, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic CancersErica S Tsang, Cameron J Grisdale, Erin Pleasance, et al.
Science (New York, N.Y.)|September 1, 2022
Cyclic ADP ribose isomers: Production, chemical structures, and immune signalingMohammad K Manik, Yun Shi, Sulin Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2020
Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencingMy Linh Thibodeau, Kieran O'Neill, Katherine Dixon, et al.
Cancer Discovery|September 22, 2020
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in <i>PIK3CA</i>-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Joline S J Lim, Iain R Macpherson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast CancerJoline S J Lim, Andrea L A Wong, Samuel G W Ow, et al.
Nature Communications|November 12, 2025
A non-canonical lymphoblast in refractory childhood T-cell leukaemiaBram S J Lim, Holly J Whitfield, Mi K Trinh, et al.
Acta Neurochirurgica|February 24, 2001
A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular DiseaseD H Han, O K Kwon, B J Byun, et al.
Annals of Surgical Oncology|September 7, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Pageof 168